Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-16
1996-10-22
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514285, 546 48, 546 62, C07D49104
Patent
active
055677070
ABSTRACT:
Compounds of formula (I): ##STR1## wherein R.sub.3, R.sub.4, R.sub.5, R.sub.6, X and Y are defined in the description.
Those compounds are used therapeutically in the treatment of cancerous tumours.
REFERENCES:
patent: 3621041 (1971-11-01), Kwok
patent: 3624087 (1971-11-01), Beck
patent: 3657249 (1972-04-01), Booher et al.
patent: 3673163 (1972-06-01), Walkling
patent: 3715359 (1973-06-01), Sullivan
patent: 3943137 (1976-03-01), Higuchi et al.
Mitaku et al. Chemical Abstr vol. 109 entry 129396 (1988).
Drummond et al. Chem. Abstr vol. 47 entry 3862 b (1953).
Atassi Ghanem
Koch Michel
Pierre Alain
Rolland Yves
Skaltsounis Alexios-Leandros
Adir et Compagnie
Daus Donald G.
LandOfFree
Acronycine analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acronycine analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acronycine analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358840